Bank Julius Baer & Co
GH icon

Bank Julius Baer & Co’s Guardant Health GH Stock Holding History

Bank Julius Baer & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,620
Closed -$162K – 665
2021
Q4 		$162K Buy
1,620
+620
+62% +$64.1K ﹤0.01% 565
2021
Q3 		$125K Sell
1,000
-296
-23% -$35.2K ﹤0.01% 612
2021
Q2 		$161K Buy
1,296
+296
+30% +$39.8K ﹤0.01% 594
2021
Q1 		$153K Sell
1,000
-75,831
-99% -$11.5M ﹤0.01% 576
2020
Q4 		$9.9M Buy
76,831
+30,454
+66% +$3.5M 0.08% 143
2020
Q3 		$5.18M Buy
46,377
+15,896
+52% +$1.45M 0.05% 155
2020
Q2 		$2.46M Sell
30,481
-5,965
-16% -$481K 0.03% 182
2020
Q1 		$2.53M Buy
+36,446
New +$2.8M 0.06% 135

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank Julius Baer & Co's GH Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Guardant Health (GH) in Q1 2022, closing a stake of 1,620 shares — an estimated $162K sold.

Bank Julius Baer & Co first reported a position in GH in Q1 2020 and held it in 8 quarters. The position peaked at $9.9M in Q4 2020. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,620 Guardant Health shares in Q1 2022, an estimated $162K.
  • Bank Julius Baer & Co first reported a position in Guardant Health in Q1 2020 and held it in 8 quarters.
  • Bank Julius Baer & Co's Guardant Health position peaked at $9.9M in Q4 2020.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.